Cost-utility and cost-benefit analysis of TAVR availability in the US severe symptomatic aortic stenosis patient population
暂无分享,去创建一个
J. Sevilla | David E. Bloom | M. Russo | X. Jiao | S. Clancy | J. Sevilla | Jessica M Klusty | Christin A Thompson | Y. Song | Jessica M. Klusty